Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OCRELIZUMAB vs OCRIPLASMIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OCRELIZUMAB vs OCRIPLASMIN: Safety Overview

Metric OCRELIZUMAB OCRIPLASMIN
Total FAERS Reports 56,186 306
Deaths Reported 1,406 2
Death Rate 2.5% 0.7%
Hospitalizations 10,364 7
Average Patient Age 47.2 yrs 65.7 yrs
% Female Patients 72.5% 73.1%
Manufacturer Genentech, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription Prescription